“In Huntington disease, we want to track the neuropathological and the clinical progression, and we want to make sure these are sensitive to potential disease-modifying treatments, which I’ll talk about in a little bit. The most commonly used…
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O’Shea, MD, MSc | NeurologyLive
